{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:15:22Z","timestamp":1783142122050,"version":"3.54.6"},"reference-count":23,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2026,6,30]]},"DOI":"10.7883\/yoken.jjid.2025.284","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:10:42Z","timestamp":1782771042000},"source":"Crossref","is-referenced-by-count":0,"title":["Disease burden and quality of life in caregivers of infants with RSV lower respiratory tract infections in Japan"],"prefix":"10.7883","author":[{"given":"Ataru","family":"Igarashi","sequence":"first","affiliation":[{"name":"Department of Public Health, Yokohama City University School of Medicine, Japan"},{"name":"Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koo","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demont","family":"Clarisse","sequence":"additional","affiliation":[{"name":"Medical Department, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Arashiro","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines Medical, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Ohata","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Ohkusu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Shizuno","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chiba Kaihin Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba Kaihin Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba Kaihin Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba Kaihin Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba Kaihin Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Chiba Children's Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Arii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba Rosai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Hishiki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Teikyo University Chiba Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setsuo","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Teikyo University Chiba Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seikei-kai Chiba Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Omata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seikei-kai Chiba Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seikei-kai Chiba Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Someya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Goi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiko","family":"Ishiwada","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev. 2014;35:519\u201330.","DOI":"10.1542\/pir.35.12.519"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399:2047\u201364.","DOI":"10.1016\/S0140-6736(22)00478-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nagasawa K, Ohata M, Igarashi A, et al. Prospective hospital-based cohort studies of respiratory syncytial virus (RSV) infections in infants under one year during and after the SARS-CoV-2 pandemic in Japan. Int J Infect Dis. 2024;149:107252.","DOI":"10.1016\/j.ijid.2024.107252"},{"key":"4","unstructured":"4. The certified NPO \u201cKEEP SMILING\u201d. Survey on the living conditions of families accompanying hospitalized children; 2022, Japanese. Available at <https:\/\/momsmile.jp\/wp\/wp-content\/uploads\/2023\/06\/a7b63100c25f4547c15be124e0e70e25.pdf> Accessed December 20, 2025."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tanaka M, Morioka I, Yu Funakoshi Y, et al. Impact of Child Respiratory Syncytial Virus-Confirmed Infections on Caregivers in Japan: A Web-Based Survey. J Clin Med. 2024;13:5355.","DOI":"10.3390\/jcm13185355"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Papi A, Ison MG, Langley, et al. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med. 2023;388:595\u2013608.","DOI":"10.1056\/NEJMoa2209604"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kampmann B, Madhi SA, Munjal I, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023;388:1451\u201364.","DOI":"10.1056\/NEJMoa2216480"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hammitt LL, Dagan R, Yuan Y, et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386:837\u201346.","DOI":"10.1056\/NEJMoa2110275"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jabagi MJ, Cohen J, Bertrand M, et al. Nirsevimab effectiveness at preventing RSV-related hospitalization in infants. NEJM Evid. 2025;4:EVIDoa2400275.","DOI":"10.1056\/EVIDoa2400275"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. L\u00f3pez-Lacort M, Mu\u00f1oz-Quiles C, Mira-Iglesias A, et al. Nirsevimab effectiveness against severe respiratory syncytial virus infection in the primary care setting. Pediatrics. 2025;155:e2024066393.","DOI":"10.1542\/peds.2024-066393"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wadia U, Moore HC, Richmond PC, et al. Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024. J Infect. 2025;90:106466.","DOI":"10.1016\/j.jinf.2025.106466"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ares-G\u00f3mez S, Mallah N, Santiago-P\u00e9rez MI, et al. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. Lancet Infect Dis. 2024;24:817\u201328.","DOI":"10.1016\/S1473-3099(24)00215-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Noto S, Kieffer A, Soudani S, et al. Cost-effectiveness and public health impact of universal prophylaxis with nirsevimab against respiratory syncytial virus (RSV) infections in all infants in Japan. Infect Dis Ther. 2025;14:847\u201365.","DOI":"10.1007\/s40121-025-01134-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ishiwada N, Akaishi R, Kobayashi Y, et al. Cost-effectiveness analysis of maternal respiratory syncytial virus vaccine in protecting infants from RSV infection in Japan. Infect Dis Ther. 2024;13:1665\u201382.","DOI":"10.1007\/s40121-024-01000-6"},{"key":"15","unstructured":"15. Ikeda S. Economic evaluation in healthcare services: on the issue of vaccination. J Natl Inst Public Health. 2013;62:599\u2013604. Japanese"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lakdawalla DN, Doshi JA, Garrison LP Jr, et al. Defining elements of value in health care-A health economics approach: an ISPOR special task force report [3]. Value Health. 2018;21:131\u20139.","DOI":"10.1016\/j.jval.2017.12.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ohno S, Chen Y, Sakamaki H, et al. Humanistic burden among caregivers of patients with Alzheimer\u2019s disease or dementia in Japan: a large-scale cross-sectional survey. J Med Econ. 2021;24:181\u201392.","DOI":"10.1080\/13696998.2021.1877149"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hirose C, Fujii H, Iihara H, et al. Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy. Support Care Cancer. 2020;28:5943\u201352.","DOI":"10.1007\/s00520-020-05443-8"},{"key":"19","unstructured":"19. VIDAL Medicament. BEYFORTUS 100 mg sol inj ser preremplie, Available at <https:\/\/www.vidal.fr\/medicaments\/beyfortus-100-mg-sol-inj-ser-preremplie-242584.html> Accessed December 20, 2025."},{"key":"20","unstructured":"20. The Ministry of Health, Labour and Welfare in Japan. The Minute of 28th meeting of the vaccine evaluation subcommittee, committee of the vaccination basic policy, the Health Science Council, the MHLW; 2024, Available at <https:\/\/www.mhlw.go.jp\/stf\/newpage_46921.html> Accessed December 20, 2025."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Postma M, Biundo E, Chicoye A, et al. Capturing the value of vaccination within health technology assessment and health economics: country analysis and priority value concepts. Vaccine. 2022;40:3999\u20134007.","DOI":"10.1016\/j.vaccine.2022.04.026"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lamsal R, Yeh EA, Pullenayegum E, et al. A systematic review of methods used by pediatric cost-utility analyses to include family spillover effects. Pharmacoeconomics. 2024;42:199\u2013217.","DOI":"10.1007\/s40273-023-01331-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Biundo E, Dronova M, Chicoye A, et al. Capturing the value of vaccination within health technology assessment and health economics-practical considerations for expanding valuation by including key concepts. Vaccines (Basel). 2024;12:773.","DOI":"10.3390\/vaccines12070773"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2025.284\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:17:54Z","timestamp":1783138674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2025.284\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2025.284","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"JJID.2025.284"}}